Affini-T Therapeutics, Inc.
1 clinical trials · Sponsor
◉ Watch Affini-T Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Phase I Study of Autologous CD8+ and CD4+ Engineered T Cell Receptor T Cells in Subjects With Advanced or Metastatic Solid Tumor (NCT06105021) | Affini-T Therapeutics, Inc. | 2024-03-06 |
Track Affini-T Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.